Unique ID issued by UMIN | UMIN000042720 |
---|---|
Receipt number | R000048757 |
Scientific Title | A study to compare the absorbency after test food intake. |
Date of disclosure of the study information | 2020/12/12 |
Last modified on | 2021/05/06 09:14:25 |
A study to compare the absorbency after test food intake.
A study to compare the absorbency after test food intake.
A study to compare the absorbency after test food intake.
A study to compare the absorbency after test food intake.
Japan |
None
Not applicable | Adult |
Others
NO
To examine the absorbability of three types of test foods.
Bio-availability
AUC
Cmax
Tmax
T1/2
Interventional
Cross-over
Randomized
Individual
Double blind -all involved are blinded
Active
YES
NO
Institution is not considered as adjustment factor.
YES
No need to know
3
Prevention
Food |
Single intake of food A and placebo-Wash out-Single intake of food B-Wash out-Single intake of food C and placebo
Single intake of food B-Wash out-Single intake of food C and placebo-Wash out-Single intake of food A and placebo
Single intake of food C and placebo-Wash out-Single intake of food A and placebo-Wash out-Single intake of food B
20 | years-old | <= |
60 | years-old | > |
Male and Female
1)Japanese healthy males and females aged from 20 to 59 years old
2)Subjects who can visit the medical institution where the test is conducted on the scheduled visit date and can be hospitalized for 2 nights and 3 days in this test
3)Subjects who have an ability to understand the purpose and contents of this clinical trial and voluntarily
applied and agreed to participate in
this clinical trial after the explanation
of this clinical trial
1)Subjects who regularly use foods containing the ingredients used in this test
2)Subjects who usually intake a food for specified health use, functional food and health foods
3)Subjects who weigh 40 kg or less or 100 kg or more, or who have a BMI of 31 or more
4)Subjects who are under treatment or have a history of serious heart disease, lung disease, gastrointestinal disease, hypertension, diabetes, or malignant neoplasms
5)Subjects who usually intake drug
6)Subjects who are pregnant, lactation, or planning to become pregnant
7)Subjects who are sensitive to test product or other foods, and medical products
8)Subjects who have collected more than 200 mL of blood 4 weeks before
the Screening test or 400 mL of blood before 16 weeks before the Screening test
9)Subjects who have had a bad mood or poor physical condition due to blood sampling in the past
10)Subjects who participated in other clinical studies
11)Subjects who are judged as unsuitable for this study by the principal investigator for other reasons
24
1st name | Kazumoto |
Middle name | |
Last name | Sasaki |
Medical Corporation Ichigenkai
Sasaki Memorial Hospital
359-1144
1-7-25, Nishitokorozawa, Tokorozawa Shi, Saitama Ken, Japan
04-2923-1123
soumuka@sasaki-memorial.com
1st name | Fukuko |
Middle name | |
Last name | Kubota |
APO PLUS STATION CO., LTD.
CRO Department Clinical Operations Division
103-0027
2-14-1,Nihonbashi,Chuo-ku,Tokyo, JAPAN
03-6386-8809
food-contact@apoplus.co.jp
APO PLUS STATION CO., LTD.
THERAVALUES CORPORATION
Profit organization
Kanazawabunko Hospital IRB
2-6-22,Kamariyahigashi,Kanazawa-ku,Yokohama-shi,Kanagawa-ken,Japan
045-785-3311
h.itou@kanabun-hp.jp
NO
2020 | Year | 12 | Month | 12 | Day |
Unpublished
24
Completed
2020 | Year | 11 | Month | 27 | Day |
2020 | Year | 11 | Month | 27 | Day |
2020 | Year | 12 | Month | 12 | Day |
2021 | Year | 01 | Month | 31 | Day |
2020 | Year | 12 | Month | 10 | Day |
2021 | Year | 05 | Month | 06 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000048757